Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue

被引:125
作者
Skliris, GP
Parkes, AT
Limer, JL
Burdall, SE
Carder, PJ
Speirs, V
机构
[1] St James Univ Hosp, Mol Med Unit, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England
关键词
ER beta; immunohistochemistry; immunoblotting; flow cytometry; mammary gland;
D O I
10.1002/path.1077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two oestrogen receptors, ERalpha and ERbeta, exist. While much is known about ERalpha, the role of ERbeta is still undefined, especially at the protein level. The aim of this study was to determine the utility of seven ERbeta antibodies (14C8, 8D5, PA1313, PPG5/10, N19, 9.88, and D7N) raised against different domains of ERbeta in three commonly used laboratory applications, namely, immunohistochemistry, western blot, and flow cytometry, using human breast material. For immunohistochemical analysis of frozen material, PA1313 and D7N gave stronger and more specific signals than 14C8, 8D5, and PPG5/10. In paraffin sections, 14C8, closely followed by PPG5/10, gave by far the most superior nuclear immunoreactivity, compared with the other antibodies tested. In general, flow, cytometry results mirrored the immunohistochemistry data for paraffin sections, with antibodies ranked 14C8 > 8D5 greater than or equal to PAI-313 > PPG5/10 > D7N. For western blotting, 8135 and D7N yielded the strongest and most consistent bands, with weaker bands seen with the others. It is concluded that ERbeta protein can be detected using specific antibodies. However, there is onsiderable variation between the specificity and application of these antibodies, highlighting the fact that careful optimization is required when selecting an antibody for use in a particular laboratory technique. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 34 条
  • [1] A novel human estrogen receptor β:: Identification and functional analysis of additional N-terminal amino acids
    Bhat, RA
    Harnish, DC
    Stevis, PE
    Lyttle, CR
    Komm, BS
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 67 (03) : 233 - 240
  • [2] Dotzlaw H, 1999, CANCER RES, V59, P529
  • [3] Expression of estrogen receptor-beta in human breast tumors
    Dotzlaw, H
    Leygue, E
    Watson, PH
    Murphy, LC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) : 2371 - 2374
  • [4] Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern
    Enmark, E
    Pelto-Huikko, M
    Grandien, K
    Lagercrantz, S
    Lagercrantz, J
    Fried, G
    Nordenskjöld, M
    Gustafsson, JÅ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4258 - 4265
  • [5] Fuqua SAW, 1999, CANCER RES, V59, P5425
  • [6] HUMAN ESTROGEN-RECEPTOR CDNA - SEQUENCE, EXPRESSION AND HOMOLOGY TO V-ERB-A
    GREEN, S
    WALTER, P
    KUMAR, V
    KRUST, A
    BORNERT, JM
    ARGOS, P
    CHAMBON, P
    [J]. NATURE, 1986, 320 (6058) : 134 - 139
  • [7] SEQUENCE AND EXPRESSION OF HUMAN ESTROGEN-RECEPTOR COMPLEMENTARY-DNA
    GREENE, GL
    GILNA, P
    WATERFIELD, M
    BAKER, A
    HORT, Y
    SHINE, J
    [J]. SCIENCE, 1986, 231 (4742) : 1150 - 1154
  • [8] Iwao K, 2000, INT J CANCER, V88, P733, DOI 10.1002/1097-0215(20001201)88:5<733::AID-IJC8>3.3.CO
  • [9] 2-D
  • [10] Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer
    Järvinen, TAH
    Pelto-Huikko, M
    Holli, K
    Isola, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) : 29 - 35